Compare INGR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INGR | BRKR |
|---|---|---|
| Founded | 1906 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 5.6B |
| IPO Year | 1997 | 2000 |
| Metric | INGR | BRKR |
|---|---|---|
| Price | $113.66 | $33.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $133.50 | $49.54 |
| AVG Volume (30 Days) | 505.3K | ★ 1.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.88% | 0.59% |
| EPS Growth | ★ 15.14 | N/A |
| EPS | ★ 11.18 | N/A |
| Revenue | ★ $7,219,000,000.00 | $1,895,600,000.00 |
| Revenue This Year | $4.04 | $6.27 |
| Revenue Next Year | $2.96 | $3.78 |
| P/E Ratio | $10.18 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $102.31 | $28.53 |
| 52 Week High | $141.78 | $56.22 |
| Indicator | INGR | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 30.63 |
| Support Level | $109.78 | $29.54 |
| Resistance Level | $113.90 | $35.15 |
| Average True Range (ATR) | 2.21 | 1.60 |
| MACD | -0.30 | -0.30 |
| Stochastic Oscillator | 41.65 | 15.00 |
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients that include starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.